{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:47:15Z","timestamp":1790812035192,"version":"4.1.0"},"reference-count":25,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100009754","name":"Galderma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009754","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Therapy"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1111\/dth.15180","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T04:44:07Z","timestamp":1635482647000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["<scp>Long\u2010term<\/scp>\n                    inflammatory rosacea management with subantibiotic dose oral doxycycline 40\u2009mg modified\u2010release capsules once daily"],"prefix":"10.1155","volume":"35","author":[{"given":"James Q.","family":"Del Rosso","sequence":"first","affiliation":[{"name":"JDR Dermatology Research Thomas Dermatology  Las Vegas Nevada USA"},{"name":"Clinical Research and Strategic Development Advanced Dermatology and Cosmetic Surgery  Maitland Florida USA"},{"name":"Adjunct Clinical Professor (Dermatology) Touro University Nevada  Henderson Nevada USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Brantman","sequence":"additional","affiliation":[{"name":"Galderma Laboratories, L.P.  Fort Worth Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Baldwin","sequence":"additional","affiliation":[{"name":"The Acne Treatment and Research Center  Brooklyn New York USA"},{"name":"Department of Dermatology Rutgers Robert Wood Johnson Medical Center  New Brunswick New Jersey USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/19381980.2017.1361574"},{"key":"e_1_2_8_3_1","first-page":"159","article-title":"Update on the management of rosacea","volume":"8","author":"Weinkle AP","year":"2015","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"6","key":"e_1_2_8_4_1","first-page":"641","article-title":"Combined effect of anti\u2010inflammatory dose doxycycline (40\u2010mg doxycycline, usp monohydrate controlled\u2010release capsules) and metronidazole topical gel 1% in the treatment of rosacea","volume":"6","author":"Fowler JF","year":"2007","journal-title":"J Drugs Dermatol"},{"issue":"7","key":"e_1_2_8_5_1","first-page":"664","article-title":"Anti\u2010inflammatory dose doxycycline in the treatment of rosacea","volume":"8","author":"Del Rosso JQ","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2010.03.015"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02850193"},{"key":"e_1_2_8_8_1","first-page":"CD003262","article-title":"Interventions for rosacea","volume":"4","author":"Zuuren EJ","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.01.023"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.11.021"},{"issue":"5","key":"e_1_2_8_11_1","first-page":"7","article-title":"An open\u2010label, community\u2010based, 12\u2010week assessment of the effectiveness and safety of monotherapy with doxycycline 40 mg (30\u2010mg immediate\u2010release and 10\u2010mg delayed\u2010release beads)","volume":"86","author":"Webster GF","year":"2010","journal-title":"Cutis"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.6.679"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09894.x"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0281-x"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03751.x"},{"issue":"6","key":"e_1_2_8_16_1","first-page":"703","article-title":"Effectiveness and safety of modified\u2010release doxycycline capsules once daily for papulopustular rosacea monotherapy results from a large community\u2010based trial in subgroups based on gender","volume":"11","author":"Del Rosso JQ","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.2165\/11204850-000000000-00000"},{"issue":"5","key":"e_1_2_8_18_1","first-page":"16","article-title":"Effectiveness and safety of doxycycline 40 mg (30\u2010mg immediate\u2010release and 10\u2010mg delayed\u2010release beads) once daily as add\u2010on therapy to existing topical regimens for the treatment of papulopustular rosacea: results from a community\u2010based trial","volume":"86","author":"Del Rosso JQ","year":"2010","journal-title":"Cutis"},{"issue":"5","key":"e_1_2_8_19_1","first-page":"26","article-title":"A community\u2010based study of the effectiveness of doxycycline 40 mg (30\u2010mg immediate\u2010release and 10\u2010mg delayed\u2010release beads) on quality of life and satisfaction with treatment in participants with rosacea","volume":"86","author":"Baldwin H","year":"2010","journal-title":"Cutis"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1159\/000235550"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13408"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13203"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13537"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2012.11.022"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2018.12.001"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-018-0249-y"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dth.15180","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dth.15180","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dth.15180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T12:58:41Z","timestamp":1671800321000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.15180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1111\/dth.15180"],"URL":"https:\/\/doi.org\/10.1111\/dth.15180","archive":["Portico"],"relation":{},"ISSN":["1396-0296","1529-8019"],"issn-type":[{"value":"1396-0296","type":"print"},{"value":"1529-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,2]]},"assertion":[{"value":"2021-09-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}